You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
眾生藥業(002317.SZ):眾生睿創擬以現金增資方式引入投資者
格隆匯 12-30 22:13

格隆匯12月30日丨眾生藥業(002317.SZ)公佈,為了繼續補充創新藥研發項目的資金,推進公司發展和創新藥研發項目進程,公司控股子公司廣東眾生睿創生物科技有限公司(“眾生睿創”)擬以現金增資方式引入投資者,新增註冊資本人民幣1392.8264萬元,由此次新引入投資者廣州宜創達創業投資合夥企業(有限合夥)(“廣州宜創達”)、深圳市倚鋒邑景創業投資合夥企業(有限合夥)(“深圳倚鋒”)、武漢市倚鋒灼華創業投資合夥企業(有限合夥)(“武漢倚鋒”)、萬聯廣生投資有限公司(“萬聯廣生”)、廣州生物島產業投資基金合夥企業(有限合夥)(“廣州生物島”)及眾生睿創現股東LBC Sunshine Healthcare Fund II L.P. (“LBC”)、眾生藥業合計以人民幣33499萬元和美元500萬元全額認繳本次新增註冊資本,超出部分計入眾生睿創的資本公積。

同時,眾生睿創現股東Southern Orchard Limited (“Southern Orchard”)將(1)其持有的A輪註冊資本(人民幣292.7942萬元)以人民幣7000萬元轉讓給廣州宜創達;(2)其持有的A輪註冊資本(人民幣104.5694萬元)以人民幣2500萬元轉讓給深圳倚鋒;(3)其持有的A輪註冊資本(人民幣20.9139萬元)以人民幣500萬元轉讓給武漢倚鋒。眾生睿創現股東Bio Track Capital Fund I,LP (“BioTrack”)將(1)其持有的A輪註冊資本(人民幣83.6555萬元)以人民幣2,000萬元轉讓給武漢倚鋒;(2)其持有的A輪註冊資本(人民幣35.7108萬元)以人民幣853.76萬元轉讓給萬聯廣生;(3)其持有的B輪註冊資本(人民幣27.0308萬元)以人民幣646.24萬元轉讓給萬聯廣生。

眾生睿創現有股東:廣東博觀元創生物科技研究中心(有限合夥)(“元創生物”)、Snow Owl,LLC (“Snow Owl”)、東莞睿創醫藥研究開發中心(有限合夥)(“睿創醫藥”)、湖州景鑫股權投資合夥企業(有限合夥)、江蘇紫金弘雲健康產業投資合夥企業(有限合夥)、青島信鴻創業投資合夥企業(有限合夥)、交銀科創股權投資基金(上海)合夥企業(有限合夥)、杭州向康倚鋒創業投資合夥企業(有限合夥)以及周雪莉女士放棄本次對眾生睿創增資的優先認購權及本次股權轉讓的優先購買權。公司及LBC放棄此次眾生睿創股權轉讓的優先購買權。Southern Orchard及BioTrack放棄此次對眾生睿創增資的優先認購權。

公司此次以自有資金出資人民幣1.7億元,認繳本次新增註冊資本639.9646萬元,超出部分計入眾生睿創的資本公積。此次控股子公司眾生睿創增資完成後,其註冊資本由人民幣15057.9915萬元增加至人民幣16450.8179萬元,公司持股比例由62.51%變為61.11%,眾生睿創仍為公司控股子公司。董事會同意授權公司董事長根據具體情況實施相關事宜並簽署有關協議及文件。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account